RE:RE:Richmond club presentationGV, thanks for the concise summary.
The key to me is "As he says Resverlogix is no longer a one trick pony. It is a science platform." I have believed this for a long time. RVX and Zenith are not just rvx-208 and zen3694. These companies are really about a system of BET inhibitor development and as Don says, and I have doubted but am now beginning to believe, is 8 years or more advanced vs any competitor. In fact, from various posts I sense that competitors, if they exist, are on the wrong track. We must remember that from Dr Wong "RVX-208 modulates gene transcription and has effects on pathways known to play important roles in CVD risks including the complement, coagulation, inflammation, and metabolism as well as increasing levels of the apolipoprotein A-I (apoAI), the major protein in high density lipoprotein(HDL)."
So, among many benefits, apabetalone increases good, functional HDL cholesterol which may in turn explain the dramatic relative risk reduction in major cardiovascular events (MACE).
Very pleased that there are 2 deals in the works!
So GLTA
Toinv